You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 1, January 7, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Scientific Misconduct Process

A Scientist's View From the Inside

Julius S. Youngner, ScD

JAMA. 1998;279:62-64.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE REVIEW PROCESS provided by the Research Integrity Adjudications Panel (RIAP) at the US Department of Health and Human Services Departmental Appeals Board (DAB) received a great deal of attention in the wake of the Imanishi-Kari decision issued in June 1996. As an active member of the research community, I have been interested in our ongoing attempts to address the problem of scientific misconduct, a problem that has demanded more attention as research has expanded and the competition for funding has affected every program. My perspective on this problem has been influenced by being the only scientist who has served on 2 RIAPs and worked with members of the DAB. The Imanishi-Kari case, in particular, demonstrated to me how important adversarial adjudication is for a fair and just outcome. Some critics attacked the RIAP process itself as unnecessary or lacking in expertise. I believe that the . . . [Full Text of this Article]

Investigation Alone Does Not Provide Adequate Due Process Guarantees

From the Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pa.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Evaluation of the Research Norms of Scientists and Administrators Responsible for Academic Research Integrity
Stanley G. Korenman, Richard Berk, Neil S. Wenger, and Vivian Lew
JAMA. 1998;279(1):41-47.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dealing with research misconduct in the United Kingdom • An American perspective on research integrity • Conduct unbecoming---the MRC's approach • An editor's response to fraudsters • Deception: difficulties and initiatives • Honest advice from Denmark
Rennie et al.
BMJ 1998;316:1726-1733.
FULL TEXT  

Standards for Scientific Behavior and Research Integrity
Jung et al.
JAMA 1998;279:1067-1068.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.